For qualified researchers, 21+. In vitro laboratory research only. Not for human or veterinary use.

Peptides

IGF-1 LR3

A modified IGF-I analog represented in cell-based receptor-activation studies.

$105

Per unit

1

For in vitro laboratory research only. Not for human or veterinary use, or as a dietary supplement.

View Certificate of Analysis

Research profile

Scientific background

Receptor studies

IGF-1 LR3 is a modified insulin-like growth factor I analog. The cited cell study compares IGF-I receptor activation across related peptides and concentration ranges, illustrating how assay design influences structure–activity comparisons.

Laboratory research topics

  • Cell-based IGF-I receptor-activation measurements.
  • Concentration–response comparisons with related peptide preparations.

Evidence in context

Original cell-based receptor study

The study did not find uniformly greater receptor potency than native IGF-I. IGF-1 LR3 and native IGF-I are distinct molecules, and assay-specific findings should not be generalized.

Published studies describe their own experimental models and preparations. They do not establish the identity, quality, or suitability of an EliteGen batch for a particular experiment.

References 1
  1. Potency of Full-Length MGF to Induce Maximal Activation of the IGF-I R Is Similar to Recombinant Human IGF-I at High Equimolar Concentrations

    2016 · Original cell-based receptor-activation study

Product documents

Certificate of Analysis

IGF-1 LR3 · 1 mg
COA not yet available for 1 mg

For document availability, contact info@elitegenresearch.com.

Specifications & Documents

Compound
IGF-1 LR3
Selected amount
1 mg
Country of Manufacture
USA
Intended use
In vitro laboratory research only
Certificate of Analysis
COA not yet available for the selected amount.
COA coverage
Report-specific samples and lots.

Review the applicable batch documents before purchasing. Catalogue information is not a batch-specific certificate of analysis.